Head of Investor Relations
Enanta Pharmaceuticals Inc (ENTA)Equibles does not estimate personal net worth.
Get an email with a short summary when Enanta Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get ENTA alertsJennifer Viera is recorded as Head of Investor Relations at Enanta Pharmaceuticals Inc (ENTA). Jennifer Viera has spoken on 16 earnings calls across 1 company, most recently for Enanta Pharmaceuticals Inc on May 6, 2024. Enanta Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Enanta Pharmaceuticals Inc includes Harry R. Trout, III (CFO), Paul Mellett (CFO), Tara L. Kieffer, Ph.D. (COO) and 5 others.
“The news release with our fiscal second quarter financial results was issued this afternoon and is available on our website. Making remarks on today's call are Dr. Jay Luly, President and Chief Executive Officer; and Paul Mellett, our Chief Financial Officer.”
“The news release with our fiscal first quarter financial results was issued this afternoon and is available on our website. Making remarks on today's call are Dr. Jay Luly, President and Chief Executive Officer; and Paul Mellett, our Chief Financial Officer.”
“The news release with our fiscal fourth quarter and year-end 2023 financial results was issued this afternoon and is available on our website. Making formal remarks on today's call are Dr. Jay Luly, President and Chief Executive Officer; and Paul Mellett, our Chief Financial Officer.”
“The news release with our fiscal third quarter 2023 financial results was issued this afternoon and is available on our website.”
“The news release with our fiscal second quarter 2023 financial results was issued this afternoon and is available on our website. A news release with top line data from our SPRINT clinical trial was also issued this afternoon and can be found on our website as well.”
Biotechnology · Healthcare
Head of Investor Relations
